NeoGenomics, Inc. Total Contract Liability
NeoGenomics, Inc. (NEO) had Total Contract Liability of $528.00 thousand as of 2026-06-30, per its 10-Q filed 2026-07-28.
Financial Statements › Balance Sheet › Liabilities
us-gaap:ContractWithCustomerLiability · last filed 2026-07-28
- 2026-06-30: Contract with Customer, Liability $528.00K.
- 2026-03-31: Contract with Customer, Liability $899.00K.
- 2025-12-31: Contract with Customer, Liability $1.24M.
- 2025-09-30: Contract with Customer, Liability $2.08M.
| Period end | Contract with Customer, Liability |
|---|---|
| 2026-06-30 | $528.00K 10-Q · filed 2026-07-28 |
| 2026-03-31 | $899.00K 10-Q · filed 2026-04-28 |
| 2025-12-31 | $1.24M 10-Q · filed 2026-07-28 |
| 2025-09-30 | $2.08M 10-Q · filed 2025-10-28 |
| 2025-06-30 | $1.53M 10-Q · filed 2025-07-29 |
| 2025-03-31 | $1.46M 10-Q · filed 2025-04-29 |
| 2024-12-31 | $745.00K 10-K · filed 2026-02-17 |
| 2024-09-30 | $985.00K 10-Q · filed 2024-11-05 |
| 2024-06-30 | $1.32M 10-Q · filed 2024-07-30 |
| 2024-03-31 | $1.14M 10-Q · filed 2024-04-30 |
| 2023-12-31 | $2.13M 10-K · filed 2025-02-18 |
| 2023-09-30 | $3.62M 10-Q · filed 2023-11-06 |
| 2023-06-30 | $5.71M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $6.07M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $7.58M 10-K · filed 2024-02-20 |
| 2022-09-30 | $7.51M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $7.47M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $7.20M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $6.11M 10-K · filed 2023-02-24 |
| 2021-09-30 | $6.21M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $5.29M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $4.70M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $4.74M 10-K · filed 2022-02-25 |
| 2020-09-30 | $4.37M 10-Q · filed 2020-10-29 |
| 2020-06-30 | $4.20M 10-Q · filed 2020-07-31 |
| 2020-03-31 | $3.50M 10-Q · filed 2020-04-29 |
| 2019-12-31 | $2.78M 10-K · filed 2021-02-25 |
| 2019-09-30 | $3.08M 10-Q · filed 2019-11-13 |
| 2019-06-30 | $2.88M 10-Q · filed 2019-08-07 |
| 2019-03-31 | $2.95M 10-Q · filed 2019-05-08 |
| 2018-12-31 | $2.58M 10-K · filed 2020-02-28 |
| 2018-09-30 | $2.46M 10-Q · filed 2018-11-06 |
| 2018-06-30 | $2.80M 10-Q · filed 2018-08-06 |
| 2018-03-31 | $2.71M 10-Q · filed 2018-05-08 |
| 2017-12-31 | $1.69M 10-K · filed 2019-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 20/20 Biolabs, Inc. (AIDX) | United States | $0.005B |